Patent details
LUC00104
Product Name:
Kymriah - tisagenlecleucel
Basic Information
- Publication number:
- LUC00104
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP118467570
- Legal Status:
- Inactive
- Application number:
- LUC00104
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/18/1297
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 27/08/2018
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 15/02/2019
- First Marketing Authorization date:
- 27/08/2018
- Grant date:
- 27/12/2019
- Activation date:
- Publication date:
- 21/02/2019
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 27/08/2033
- SPC Extension Expiration:
- 27/08/2033
- Rejection date:
- Withdrawal date:
Owner
- From:
- 15/02/2019
-
-
- Name:
- The Trustees of The University of Pennsylvania
- Address:
- Center for Technology Transfer
3160 Chestnut Street, Suite 200, Philadelphia PA 19104-6283, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 15/02/2019
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2019/04
- Publication date:
- 11/03/2019
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2020/01
- Publication date:
- 13/01/2020
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 31/12/2031
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-